flow trial semaglutide kidney outcomes clinical (funded by Novo Nordisk): showed 24% reduction in the risk of disease-related events in people with type 2 diabetes and chronic kidney disease compared to placebo. Investigators ❇️Patients with obesity, type 2

How protein shakes may provide support: Protein shakes offer a nutrient-dense option that requires minimal chewing and digestion, which can be advantageous when solid foods are poorly tolerated

S.BhattacharyyaT

Antonina Sidoti, orcid.org/0000-0001-6980-7548 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

We also noted that giving ACOs longer than 7 years or potentially unlimited time under a one-sided model would dilute the program's ability to meaningfully influence expenditures and quality through the incentives provided by ACO risk assumption

Calculation Catastrophes: Misplacing a decimal point can lead to a dose thats 10x too high or 10x too low, completely invalidating your data